Canopus Biopharma Inc (CE) (CBIA) Actualités

Form 1-A-W - Withdrawal of offering statement [Regulation A]

Form 1-A POS -

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 253G2 -

Form 253G1 -

Form QUALIF - Notice of Qualification [Regulation A]

Form 1-A POS -

Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)

Filed Pursuant to Rule 253(g)(2) File No. 024-12248     Offering Circular Supplement Dated May 23, 2023   An Offering...

Reflects Information Previously Omitted From the Offering Circular in Reliance on Rule 253(b) (253g1)

Filed Pursuant to Rule 253(g)(1) File No. 024-12248     OFFERING CIRCULAR   Blue Heaven Coffee, Inc. (formerly Canopus BioPharma...

Registration a Offering Under the Securities Act of 1933 (1-a)

Form 1-A Issuer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-A...

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study PR Newswire LOS ANGELES, Dec. 19, 2014 LOS ANGELES...

Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China

Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China - Results Confirm Efficacy and Safety of an...

Major Influenza Pandemic Threat is now Preventable and Treatable with Canopus’ Aerosol Statin Formulation

Canopus BioPharma Inc. (OTCPK: CBIA) today announced it has commissioned a team of experts led by Dr. Akihiro Shimosaka, to...

Working with U.S. Department of Defense, Canopus BioPharma Announces Phase II Human Clinical Trial for Innovative Hepatitis C...

Canopus BioPharma, Inc. (OTC:CBIA);(www.canopusbiopharma.com) today announced that permission has been granted by the U.S...